Biomea Fusion, Inc. (NASDAQ:BMEA) Given Average Rating of “Buy” by Brokerages

Published on 22 Apr 2022 on ETF DAILY NEWS

Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) have received an average rating of “Buy”...

Read the rest of the article

Start tracking your investments with Statfolio

Even if it's not a huge purchase, we think it was good to see that Franco Valle, the CFO & Princi...

Simply Wall St. · via Yahoo Finance 18 Jun 2024

We recently compiled a list of What Is Short Selling In Stock Market? 15 Stocks Hedge Funds are S...

Insider Monkey · via Yahoo Finance 18 Jun 2024

We recently compiled the list of the Analysts on Wall Street Lower Ratings for These 10 Stocks. I...

Insider Monkey · via Yahoo Finance 18 Jun 2024

We recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we a...

Insider Monkey · via Yahoo Finance 18 Jun 2024

Biomea Fusion, Inc. BMEA, a clinical-stage company, is focused on the discovery and development o...

Zacks via Yahoo Finance 12 Dec 2023

Biomea Fusion, Inc. BMEA, a clinical-stage company, announced dosing the first patient in its ear...

Zacks via Yahoo Finance 18 Oct 2023

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks via Yahoo Finance 5 Oct 2023

Biomea Fusion Inc (NASDAQ: BMEA) announced the presentation of new clinical data from the first t...

Benzinga via Yahoo Finance 26 Jun 2023

Shares of Biomea Fusion Inc. jumped 17% in premarket trading Monday after the clinical-stage biop...

Market Watch 26 Jun 2023

You can always spot the best stocks after they rack up enormous gains for their shareholders. It'...

GoBankingRates via AOL 13 Jun 2023